Literature DB >> 29277306

Design, synthesis, and evaluation of polyamine-memantine hybrids as NMDA channel blockers.

Takuya Kumamoto1, Marie Nakajima2, Reina Uga2, Naoko Ihayazaka2, Haruna Kashihara2, Kazuaki Katakawa2, Tsutomu Ishikawa3, Ryotaro Saiki3, Kazuhiro Nishimura3, Kazuei Igarashi4.   

Abstract

N-Methyl-d-aspartate (NMDA) receptors have been implicated in learning and memory, and may also play a central role in various conditions leading to neuronal degradation. NMDA receptor antagonists could therefore be of therapeutic benefit for a number of neurological disorders. We have designed hybrid compounds of polyamines and memantine, both of which function as NMDA channel blockers. The triamine derivative with a guanidine moiety showed more potent antagonistic activity than memantine.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Guanidine; Memantine; NMDA channel blocker; Polyamine

Mesh:

Substances:

Year:  2017        PMID: 29277306     DOI: 10.1016/j.bmc.2017.12.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.

Authors:  Andreea L Turcu; Júlia Companys-Alemany; Matthew B Phillips; Dhilon S Patel; Christian Griñán-Ferré; M Isabel Loza; José M Brea; Belén Pérez; David Soto; Francesc X Sureda; Maria G Kurnikova; Jon W Johnson; Mercè Pallàs; Santiago Vázquez
Journal:  Eur J Med Chem       Date:  2022-04-08       Impact factor: 7.088

Review 2.  Memantine Derivatives as Multitarget Agents in Alzheimer's Disease.

Authors:  Giambattista Marotta; Filippo Basagni; Michela Rosini; Anna Minarini
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.